GelStat Breaks Into Retail With Migraine Remedy
This article was originally published in The Tan Sheet
Executive Summary
CEO Larry Gershman says GelStat will launch a marketing campaign to support extending its products for the first time to retail stores. The firm changed its sublingual migraine homeopathic to a single dose from two doses taken five minutes apart.
You may also be interested in...
Novartis Turns To OTC Co-Packers As Lincoln Plant Lags
Originally expected back online by the summer, the Novartis Consumer Health facility in Lincoln, Neb., will not ship any product in 2012. Novartis, which reported consumer sales down 22% to $938 million in Q3, is using third-party manufacturers to restore Excedrin Migraine and other OTCs to market.
Bayer Migraine Formula Seeks Market Share Before Excedrin Returns
Bayer Migraine Formula, already in major retailers nationwide, is “a welcome addition to the pain relief aisle for migraine sufferers … affected by the OTC supply issues this year,” the firm says, referring to Novartis’ voluntarily recall of Excedrin.
GelStat Migraine launch
GelStat's homeopathic remedy for "migraine and migraine-like headaches" will reach shelves at several small chains in early May followed shortly by a national Eckerd's rollout, according to the Bloomington, Minn.-based firm. Active ingredients feverfew and ginger "are combined with proprietary adjuncts to ensure rapid, effective absorption" through patented OraDose sublingual dosing system. A four-dose SKU carries a suggested retail price of $6.99. Print, radio and coupon support kicks off in July...